Well-woman visit of mothers and human papillomavirus vaccine intent and uptake among their 9-17 year old children

Mahbubur Rahman, Lee B. Elam, Michael I. Balat, Abbey Berenson

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: To examine the association between attending a well-woman clinic in the prior 2 years and obtaining the human papillomavirus (HPV) vaccine for their 9-17-year-old child. Methods: Women (n= 1256) who attended reproductive health clinics during September 2011 to February 2013 and had ≥1 children 9-17 years of age were asked to complete a self-administered questionnaire containing questions on demographic characteristics, prior well-woman visits, HPV awareness, and HPV vaccine intent and uptake among their adolescent children. Results: Nearly 78% of women reported having undergone a well-woman visit during the past 2 years. Bivariate analysis showed that the HPV vaccine initiation (23.9% vs. 14.0%, P= .004) and completion (13.6% vs. 6.7%, P= .011) among 9-17 daughters differed between mothers who did or did not have a well-woman visit during the past 2 years. However, intent to vaccinate them (47.2% vs. 53.3%, P= .173) did not differ between these two groups. With regard to 9-17 year old sons, vaccine initiation (10.1% vs. 9.6%, P= .871), completion (4.6% vs. 2.4%, P= .273) and intent to vaccinate (47.3% vs. 52.1%, P= .311) did not differ between these two groups. Multivariable logistic regression analyses confirmed the findings of these bivariate analyses after adjusting for confounder variables. Conclusion: The well-woman visit may be a missed opportunity for physicians to educate their patients about the benefits of HPV vaccination for their adolescent children in general and sons in particular. Intervention studies are warranted to assess the benefits of using this setting to improve HPV vaccine uptake in the US.

Original languageEnglish (US)
Pages (from-to)5544-5548
Number of pages5
JournalVaccine
Volume31
Issue number47
DOIs
StatePublished - Nov 12 2013

Fingerprint

Papillomavirus Vaccines
Papillomaviridae
Mothers
vaccines
uptake mechanisms
Nuclear Family
sociodemographic characteristics
Reproductive Health
physicians
Vaccination
Vaccines
questionnaires
Logistic Models
vaccination
Regression Analysis
Demography
Physicians

Keywords

  • Human papillomavirus vaccine
  • Vaccine intent
  • Vaccine uptake
  • Well-woman visit

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)
  • Molecular Medicine

Cite this

Well-woman visit of mothers and human papillomavirus vaccine intent and uptake among their 9-17 year old children. / Rahman, Mahbubur; Elam, Lee B.; Balat, Michael I.; Berenson, Abbey.

In: Vaccine, Vol. 31, No. 47, 12.11.2013, p. 5544-5548.

Research output: Contribution to journalArticle

Rahman, Mahbubur ; Elam, Lee B. ; Balat, Michael I. ; Berenson, Abbey. / Well-woman visit of mothers and human papillomavirus vaccine intent and uptake among their 9-17 year old children. In: Vaccine. 2013 ; Vol. 31, No. 47. pp. 5544-5548.
@article{1af1c52d04ac4d23a41d40e4f0d478c7,
title = "Well-woman visit of mothers and human papillomavirus vaccine intent and uptake among their 9-17 year old children",
abstract = "Objective: To examine the association between attending a well-woman clinic in the prior 2 years and obtaining the human papillomavirus (HPV) vaccine for their 9-17-year-old child. Methods: Women (n= 1256) who attended reproductive health clinics during September 2011 to February 2013 and had ≥1 children 9-17 years of age were asked to complete a self-administered questionnaire containing questions on demographic characteristics, prior well-woman visits, HPV awareness, and HPV vaccine intent and uptake among their adolescent children. Results: Nearly 78{\%} of women reported having undergone a well-woman visit during the past 2 years. Bivariate analysis showed that the HPV vaccine initiation (23.9{\%} vs. 14.0{\%}, P= .004) and completion (13.6{\%} vs. 6.7{\%}, P= .011) among 9-17 daughters differed between mothers who did or did not have a well-woman visit during the past 2 years. However, intent to vaccinate them (47.2{\%} vs. 53.3{\%}, P= .173) did not differ between these two groups. With regard to 9-17 year old sons, vaccine initiation (10.1{\%} vs. 9.6{\%}, P= .871), completion (4.6{\%} vs. 2.4{\%}, P= .273) and intent to vaccinate (47.3{\%} vs. 52.1{\%}, P= .311) did not differ between these two groups. Multivariable logistic regression analyses confirmed the findings of these bivariate analyses after adjusting for confounder variables. Conclusion: The well-woman visit may be a missed opportunity for physicians to educate their patients about the benefits of HPV vaccination for their adolescent children in general and sons in particular. Intervention studies are warranted to assess the benefits of using this setting to improve HPV vaccine uptake in the US.",
keywords = "Human papillomavirus vaccine, Vaccine intent, Vaccine uptake, Well-woman visit",
author = "Mahbubur Rahman and Elam, {Lee B.} and Balat, {Michael I.} and Abbey Berenson",
year = "2013",
month = "11",
day = "12",
doi = "10.1016/j.vaccine.2013.09.017",
language = "English (US)",
volume = "31",
pages = "5544--5548",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "47",

}

TY - JOUR

T1 - Well-woman visit of mothers and human papillomavirus vaccine intent and uptake among their 9-17 year old children

AU - Rahman, Mahbubur

AU - Elam, Lee B.

AU - Balat, Michael I.

AU - Berenson, Abbey

PY - 2013/11/12

Y1 - 2013/11/12

N2 - Objective: To examine the association between attending a well-woman clinic in the prior 2 years and obtaining the human papillomavirus (HPV) vaccine for their 9-17-year-old child. Methods: Women (n= 1256) who attended reproductive health clinics during September 2011 to February 2013 and had ≥1 children 9-17 years of age were asked to complete a self-administered questionnaire containing questions on demographic characteristics, prior well-woman visits, HPV awareness, and HPV vaccine intent and uptake among their adolescent children. Results: Nearly 78% of women reported having undergone a well-woman visit during the past 2 years. Bivariate analysis showed that the HPV vaccine initiation (23.9% vs. 14.0%, P= .004) and completion (13.6% vs. 6.7%, P= .011) among 9-17 daughters differed between mothers who did or did not have a well-woman visit during the past 2 years. However, intent to vaccinate them (47.2% vs. 53.3%, P= .173) did not differ between these two groups. With regard to 9-17 year old sons, vaccine initiation (10.1% vs. 9.6%, P= .871), completion (4.6% vs. 2.4%, P= .273) and intent to vaccinate (47.3% vs. 52.1%, P= .311) did not differ between these two groups. Multivariable logistic regression analyses confirmed the findings of these bivariate analyses after adjusting for confounder variables. Conclusion: The well-woman visit may be a missed opportunity for physicians to educate their patients about the benefits of HPV vaccination for their adolescent children in general and sons in particular. Intervention studies are warranted to assess the benefits of using this setting to improve HPV vaccine uptake in the US.

AB - Objective: To examine the association between attending a well-woman clinic in the prior 2 years and obtaining the human papillomavirus (HPV) vaccine for their 9-17-year-old child. Methods: Women (n= 1256) who attended reproductive health clinics during September 2011 to February 2013 and had ≥1 children 9-17 years of age were asked to complete a self-administered questionnaire containing questions on demographic characteristics, prior well-woman visits, HPV awareness, and HPV vaccine intent and uptake among their adolescent children. Results: Nearly 78% of women reported having undergone a well-woman visit during the past 2 years. Bivariate analysis showed that the HPV vaccine initiation (23.9% vs. 14.0%, P= .004) and completion (13.6% vs. 6.7%, P= .011) among 9-17 daughters differed between mothers who did or did not have a well-woman visit during the past 2 years. However, intent to vaccinate them (47.2% vs. 53.3%, P= .173) did not differ between these two groups. With regard to 9-17 year old sons, vaccine initiation (10.1% vs. 9.6%, P= .871), completion (4.6% vs. 2.4%, P= .273) and intent to vaccinate (47.3% vs. 52.1%, P= .311) did not differ between these two groups. Multivariable logistic regression analyses confirmed the findings of these bivariate analyses after adjusting for confounder variables. Conclusion: The well-woman visit may be a missed opportunity for physicians to educate their patients about the benefits of HPV vaccination for their adolescent children in general and sons in particular. Intervention studies are warranted to assess the benefits of using this setting to improve HPV vaccine uptake in the US.

KW - Human papillomavirus vaccine

KW - Vaccine intent

KW - Vaccine uptake

KW - Well-woman visit

UR - http://www.scopus.com/inward/record.url?scp=84886776995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886776995&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2013.09.017

DO - 10.1016/j.vaccine.2013.09.017

M3 - Article

C2 - 24099869

AN - SCOPUS:84886776995

VL - 31

SP - 5544

EP - 5548

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 47

ER -